CLINICAL_TRIALS
trial_result
· 2021-09-05
Clinical Trial Update: Study to Assess Prevention of Oxaliplatin-induced Neurotoxicity Through Vitamin D Pathway [Phase 2]
Summary
Phase 2 trial investigating vitamin D pathway to prevent oxaliplatin-induced neurotoxicity was terminated; results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gerald Higa, PharmD. | Conditions: Neurotoxicity | Phase 2 | Status: TERMINATED | Results posted: 2021-09-05